APPLICATION
BLA761298
TYPE
BLA
ORIGINAL APPROVAL
2024-08-23
LATEST ACTION
2026-04-28
ROUTE
INTRAVITREAL, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
PAVBLUPrescription
AFLIBERCEPT-AYYH 2 mg (0.05 mL of 40 mg/mL) · INJECTABLE · INJECTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.